SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J., November 07, 2025--Kardigan, a heart health company modernizing cardiovascular drug development, announced positive Phase 2 data on ataciguat in patients ...
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...
PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...
Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...
Seven-year follow-up data show that transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement have ...
News-Medical.Net on MSN
New initiative aims to accelerate aortic stenosis diagnosis and treatment
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
10don MSN
Minimally invasive procedure for aortic valve disease has similar outcomes as surgery, study reports
People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes ...
This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, USA. At ...
GlobalData on MSN
Edwards solidifies TAVR dominance in long-term trial readout
The respective readouts demonstrated TAVR’s comparable performance to surgical aortic valve replacement treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback